Combining SJ733, an oral ATP4 inhibitor of Plasmodium falciparum, with the pharmacokinetic enhancer cobicistat: An innovative approach in antimalarial drug development-Reference-Cited by-同舟云学术

Combining SJ733, an oral ATP4 inhibitor of Plasmodium falciparum, with the pharmacokinetic enhancer cobicistat: An innovative approach in antimalarial drug development

Published:2022-06 Issue: Volume:80 Page:104065
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Gaur Aditya H.^ORCID,Panetta John C.,Smith Amber M.,Dallas Ronald H.,Freeman Burgess B.,Stewart Tracy B.,Tang Li,John Elizabeth,Branum Kristen C.,Patel Nehali D.,Ost Shelley,Heine Ryan N.,Richardson Julie L.,Hammill Jared T.^ORCID,Bebrevska Lidiya,Gusovsky Fabian,Maki Noritsugu,Yanagi Toshiharu,Flynn Patricia M.,McCarthy James S.,Chalon Stephan^ORCID,Guy R. Kiplin

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference16 articles.

1. Evidence of Artemisinin-Resistant Malaria in Africa;Balikagala;N Engl J Med,2021

2. Efficacy and resistance of different artemisinin-based combination therapies: a systematic review and network meta-analysis;Mathenge;Parasitol Int,2020

3. Malaria;Phillips;Nat Rev Dis Prim,2017

4. +)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium;Jimenez-Diaz;Proc Natl Acad Sci USA,2014

5. Spiroindolone KAE609 for falciparum and vivax malaria;White;N Engl J Med,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interaction of CYP3A4 with the inhibitor cobicistat: Structural and mechanistic insights and comparison with ritonavir;Archives of Biochemistry and Biophysics;2024-08

2. Transmission-Blocking Strategies for Malaria Eradication: Recent Advances in Small-Molecule Drug Development;Pharmaceuticals;2024-07-19

3. A pH Fingerprint Assay to Identify Inhibitors of Multiple Validated and Potential Antimalarial Drug Targets;ACS Infectious Diseases;2024-03-18

4. Emerging Drug Targets for Antimalarial Drug Discovery: Validation and Insights into Molecular Mechanisms of Function;Journal of Medicinal Chemistry;2024-01-10

5. Prediction of improved antimalarial chemotherapy of artesunate-mefloquine in combination with mefloquine sensitive and resistant Plasmodium falciparum malaria;PLOS ONE;2023-02-23